List of Figure
Figure 1: Japan Active Pharmaceutical Ingredients Market Size By Value 2016 to 2027F (In USD billion)
Figure 2: Japan Active Pharmaceutical Ingredients Market Share By Volume By Synthesis Type (2016, 2021 & 2027F)
Figure 3: Japan Active Pharmaceutical Ingredients Market Share By Volume By Therapeutic Application (2016, 2021 & 2027F)
Figure 4: Japan Active Pharmaceutical Ingredients Market Share By Type of Manufacture (2016, 2021 & 2027F)
Figure 5: Market Attractiveness Index, By Synthesis Type
Figure 6: Market Attractiveness Index, By Therapeutic Application
Figure 7: Market Attractiveness Index, By Type of Manufacture
Figure-8: Porter's Five Forces Meter of Active Pharmaceutical Ingredients Industry in Japan
List of Table
Table 1: Japan Active Pharmaceutical Ingredients Market Size of Synthetic API (2016 to 2027F) (In USD billion)
Table 2: Japan Active Pharmaceutical Ingredients Market Size of Biotech API (2016 to 2027F) (In USD billion)
Table 3: Japan Active Pharmaceutical Ingredients Market Size of Communicable Diseases (2016 to 2027F) (In USD billion)
Table 4: Japan Active Pharmaceutical Ingredients Market Size of Oncology (2016 to 2027F) (In USD billion)
Table 5: Japan Active Pharmaceutical Ingredients Market Size of Diabetes (2016 to 2027F) (In USD billion)
Table 6: Japan Active Pharmaceutical Ingredients Market Size of Cardiovascular Disease (2016 to 2027F) (In USD billion)
Table 7: Japan Active Pharmaceutical Ingredients Market Size of Pain management (2016 to 2027F) (In USD billion)
Table 8: Japan Active Pharmaceutical Ingredients Market Size of Respiratory Diseases (2016 to 2027F) (In USD billion)
Table 9: Japan Active Pharmaceutical Ingredients Market Size of Other Therapeutic Applications (2016 to 2027F) (In USD billion)
Table 10: Japan Active Pharmaceutical Ingredients Market Size of Captive API (2016 to 2027F) (In USD billion)
Table 11: Japan Active Pharmaceutical Ingredients Market Size of Merchant API (2016 to 2027F) (In USD billion)
Table 12: Key Facts of Company 1
Table 13: Key Facts of Company 2
Table 14: Key Facts of Company 3
Table 15: Key Facts of Company 4
Table 16: Key Facts of Company 5
Table 17: Key Facts of Company 6
Table 18: Key Facts of Company 7
Table 19: Key Facts of Company 8
?
Safe and Secure SSl Encryption
Licensing options
1950
USD
You can select one of these options upon checking out
Allows one individual to access the purchased report
Allows up to five individuals to access the purchased report
Allows all employees of an organization to access the purchased report. Internal sharing only
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
Toll-free +44 800 1026595
Email us on:- sales@actualmarketresearch.com
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
Avail customized purchase options to meet your exact research needs:
Order Placed (28 November, 2023)
Notify To Team (28 November, 2023)
Report updation (29 November, 2023)
Report Quality Check (29 November, 2023)
Report Dispatch (30 November, 2023)
Hard Copy
READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.
CEO
ASHISH ARORA
BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!
EXECUTIVE DIRECTOR
RAHUL ROY
THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND ACTUAL MARKET RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.
SALES DIRECTOR
ARJUN PRASAD
THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH ACTUAL MARKET RESEARCH
President
MANISH VERMA
ACTUAL MARKET RESEARCH DID AN OUTSTANDING WORK ON GLOBAL HAND SANITIZER PROJECT. IT WAS INDEED A COMPREHENSIVE REPORT THAT GAVE US REVENUE IMPACTING SOLUTION ENABLING US TO PLAN THE RIGHT MOVE.
MARKETING DIRECTOR
BALRAJ BHANOT
THE STUDY DONE BY ACTUAL MARKET RESEARCH WAS CUSTOMIZED WITH ALL OUR NEEDS. WE WERE EXTREMELY IMPRESSED BY THE SIMPLE BUT COMPREHENSIVE PRESENTATION OF THE STUDY AND THE QUALITY OF WORK DONE.
PRODUCT MANAGER
MATTHEW
I’M GLAD I DECIDED TO WORK WITH YOU. THANKFUL TO THE TEAM FOR THE AMAZING COORDINATION, IT WAS INDEED A GOOD EXPERIENCE, WOULD DEFINITELY RECOMMEND AND COME BACK FOR FUTURE PROSPECTS.
ASSOCIATE DIRECTOR
TONNY WOOD
APIs are the ingredients that are being used in medicines to cure diseases. This API shows the intended effect on the body once it is consumed to cure diseases. These APIs have a larger market scope worldwide. The market for APIs is the fastest growing market right now in the world. The US is considered to be the major player in the world that has the most innovative production system, followed by China at second and, at third, comes the Japanese API market, which has the most innovative API in the world and is consistently dominating and giving the world the toughest competition to come up to the highest possible level. The Japanese API market is dealing with synthetic and biotech or natural APIs.
According to the Actual Market Research report titled "Japan Active Pharmaceutical Ingredient Market Overview 2027", it is observed that the Japanese API market is the fastest-growing market in the Asia Pacific region and holds the lion's share of the APAC region market. The Japanese nation is one of the healthiest nations, but an increase in chronic diseases has led to a demand for APIs. Because of the advancement in biologics, the Japanese market has an increased demand for the biotech API. These are the APIs that are being produced naturally or extracted from natural resources. Biotech APIs in Japan have dominated the market in previous years, and it is expected that they will continue to dominate the market in the coming year with a CAGR of more than 10%.
The COVID-19 standard is one of the primary factors driving the global API market due to increased incidences of health problems. Because of the increase in the demand for the vaccination, Japan has consumed more of the API in order to produce the vaccination. The major driver for the Japanese API market is the increased cases of chronic diseases that are high. The major driver for the increase in the Japanese API market is cancer or oncology diseases. Because of this, the number of deaths is increasing. The API market through the therapeutic implication of oncology or cancer diseases is expected to be over 8% CAGR in the upcoming forecasted year. The market is dominated by biotech API, which is in high demand due to the increased advancement in biologics. The Japanese nation has the most innovative technology in the world, it has led to an increase in the production and investment capacity of the API. The increase in the population of aged people is increasing, which leads to an increased number of patients among the elderly. The increased number of elderly people among the Japanese people has been the major cause of people getting infected with diseases like diabetes. The number of people infected with diabetes is increasing. Therefore, the market share for diabetes in terms of CAGR is expected to increase by over 8%. Diabetes is expected to be the world's largest disease by 2030. The consumption of APIs for oncology and diabetes is the major driver of the API market that leads to the API market's growth.
People in the nation are majorly buying the APIs through the involvement of a third party, which leads to the growth of the merchant API market size with growth in terms of CAGR. The merchant API refers to the involvement of retail stores or medical stores. Retail stores and medical stores are the major third parties that contributed to increasing the dominance of the API market in Japan. Also, Indian and Chinese firms are dominating the Japanese market by hindering the market price with lower prices.
Considered in this report
• Geography: Japan
• Historic Year: 2016
• Base year: 2021
• Estimated year: 2022
• Forecast year: 2027
Aspects covered in this report
• Japan active pharmaceutical ingredient market
• Application wise API market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
Based on synthesis type of API in the report:
• Synthetic API
• Biotech API
Based on therapeutic application type of API in the report:
• Communicable diseases
• Oncology
• Diabetes
• Cardiovascular diseases
• Pain management
• Respiratory diseases
• Other therapeutic application
By Type of manufacturer in the report:
• Captive API
• Biotech API
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to pharmaceutical industry, API manufacturing industries, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Read More